The challenges of introducing routine G6PD testing into radical cure: a workshop report. - Test2 - elhamkhani - TriplyDB

The challenges of introducing routine G6PD testing into radical cure: a workshop report.

The challenges of introducing routine G6PD testing into radical cure: a workshop report.

http://www.wikidata.org/entity/Q30666192

about

Costs and Cost-Effectiveness of Plasmodium vivax Control Evidence on anti-malarial and diagnostic markets in Cambodia to guide malaria elimination strategies and policies Recombinant human G6PD for quality control and quality assurance of novel point-of-care diagnostics for G6PD deficiency Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis.Where chloroquine still works: the genetic make-up and susceptibility of Plasmodium vivax to chloroquine plus primaquine in Bhutan.A Comparison of Three Quantitative Methods to Estimate G6PD Activity in the Chittagong Hill Tracts, Bangladesh.Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group.Comparison of Three Screening Test Kits for G6PD Enzyme Deficiency: Implications for Its Use in the Radical Cure of Vivax Malaria in Remote and Resource-Poor Areas in the Philippines Prevalence and genetic variants of G6PD deficiency among two Malagasy populations living in Plasmodium vivax-endemic areas.National G6PD neonatal screening program in Gaza Strip of Palestine: rationale, challenges and recommendations.Validation of the rapid test Carestart(tm) G6PD among malaria vivax-infected subjects in the Brazilian Amazon.Barriers to routine G6PD testing prior to treatment with primaquine.Rapid diagnostic test for G6PD deficiency in Plasmodium vivax-infected men: a budget impact analysis based in Brazilian Amazon.Methods for the field evaluation of quantitative G6PD diagnostics: a review.Systematic review of the clinical manifestations of glucose-6-phosphate dehydrogenase deficiency in the Greater Mekong Subregion: implications for malaria elimination and beyond malERA: An updated research agenda for diagnostics, drugs, vaccines, and vector control in malaria elimination and eradication.The ethics of using placebo in randomised controlled trials: a case study of a Plasmodium vivax antirelapse trial.Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia.

P2860

Q28355704-0608ECE7-50B8-4EAF-B981-83F648E26B35 Q33601258-A85120A5-D563-495B-9119-191483B0E494 Q33731882-B2761F99-021A-435B-89C0-FA5BB63B0A45 Q33769314-EF852FB5-9A89-4997-BFCE-634140D0A1AB Q36017165-002A4D6C-A5F8-45A5-A1C4-93008B1A6503 Q36259682-3620D6C4-7CA4-4E01-B349-E8E12AE575E9 Q36337171-B696C004-6892-41FE-B04D-7688B225ED8A Q36551751-FC63DC52-A018-4442-90A9-2A131E42B5AD Q37737972-9EB58E48-A5AB-4C7B-AFEC-917FA586CA38 Q38804223-567B01D9-FE5E-40B9-B45A-839F8564ACF6 Q38921632-7DE185AB-9C3D-45B5-A876-527AAB97BC36 Q39174035-066F4A60-EE61-4CDF-81D4-DD58186CF673 Q39346829-47BCA43F-056F-426C-8048-9447F44BD283 Q40053271-F469D772-E184-4F4F-91F4-754D646DF99C Q42632539-254E93BD-37C5-44A1-B318-23DFEFBECC4F Q47134819-989D7CD0-509C-4D43-A81A-2CE12307C3BB Q52808429-5BFBDE46-D977-475E-B416-E56D5156E35A Q55438871-5137183E-1122-4B0A-A9CB-00EB77FA2860

P2860

The challenges of introducing routine G6PD testing into radical cure: a workshop report.

http://www.wikidata.org/entity/Q30666192

description

2015 nî lūn-bûn

@nan

2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

The challenges of introducing routine G6PD testing into radical cure: a workshop report.

@ast

The challenges of introducing routine G6PD testing into radical cure: a workshop report.

@en

type

label

The challenges of introducing routine G6PD testing into radical cure: a workshop report.

@ast

The challenges of introducing routine G6PD testing into radical cure: a workshop report.

@en

prefLabel

The challenges of introducing routine G6PD testing into radical cure: a workshop report.

@ast

The challenges of introducing routine G6PD testing into radical cure: a workshop report.

@en

P1433

Q30666192-3BE85C55-BF4E-478D-A650-68E62229EBC2

P1476

Q30666192-25336BC3-1DD8-4258-BDE0-4DCF9CE532B7

P2093

Q30666192-19212E3B-38F0-45F4-9272-1270AD99BD71

Q30666192-1CC4B3A4-CEF2-48D6-97EB-FC9424806C52

Q30666192-200A7386-E7B6-49B2-8FBA-2448AFDB4AB1

Q30666192-23F65C48-1F91-48E0-B586-2D0110B8167B

Q30666192-3743BEF5-5E59-4159-BBC7-CAECE8DB7A19

Q30666192-3C2B97CF-D3BE-40BE-A04A-A95B91917020

Q30666192-4CE3A35D-48B8-4E97-A092-B33EA5BCA20A

Q30666192-7C3FA5CF-59D8-4DCA-A471-404B38F2AF59

Q30666192-8A3DAE38-A00A-4E1E-9F1A-1140C1CE57A1

Q30666192-926D1E0D-B261-4F7B-85BF-CFF03E9A47B0

P2860

Q30666192-04DE7F40-C079-40F5-B8C0-57907BC0887F

Q30666192-0512A908-DB5E-4493-8BAE-4C5233E9B4B6

Q30666192-140BAF51-B632-4F08-8306-ED51285FB475

Q30666192-2363C4BA-2ADD-4965-B973-0672BC349688

Q30666192-247E8B2E-2F7F-46CB-849A-3133C5F44778

Q30666192-266D2460-C9C2-4499-BB13-23BDCC5D8630

Q30666192-326FB4E9-EB0C-4E8C-9DD3-FF5DCA5BB2AA

Q30666192-342931F7-E721-4F23-95B8-630CF019D653

Q30666192-36C15DB5-BA91-471F-B5B3-F052E5CCABB6

Q30666192-37B8C544-4D90-4E23-B863-690F96072020

P2888

Q30666192-4DFF7D2A-D2C3-43E8-8D09-60AB076DDF7A

P304

Q30666192-2FEEF72A-5C51-47E6-9185-D661C9EF45E9

P31

Q30666192-19C4047F-064A-442F-B318-08ED194FF4E8

P356

Q30666192-98FA60EC-A98A-4018-BE90-BA0D1F2E64ED

P478

Q30666192-0F05CAED-CC30-4A28-B671-95C427AA0A6A

P50

Q30666192-1FC5F4B0-F2D3-4877-9F52-E45653F2B43F

Q30666192-31192FBA-7FC7-49A9-B840-AA00BB088740

Q30666192-7B5F6DD2-7618-4B56-9219-BCEDABED6D2C

Q30666192-ABF74888-0EFB-4E59-92C8-55A34A8DF113

Q30666192-BA1A33E8-87F2-487B-9116-8703CF44FD3F

Q30666192-D4B58D9C-B2B2-40BE-97C7-09A6D4F811DF

Q30666192-F7E2F265-6312-446B-BBCD-0C3055FA2F7C

P577

Q30666192-C9C31548-8EA1-4BA6-9FBA-A3100420A8D5

P5875

Q30666192-6BCD9A16-D998-4162-9EFD-053090AC86A5

P6179

Q30666192-2CE8E3B9-7F7C-4DC0-AE49-BEFB4E9153D1

P698

Q30666192-504D7DA7-0AAD-49C6-AD2C-3C4481BB6002

P921

Q30666192-BEAD9086-F5DD-4330-8AAA-5CCE58D567D1

P932

Q30666192-71E6B97B-9834-4016-AD21-7BCC49AB8E18

P356

S12936-015-0896-8

P1433

Malaria Journal

P1476

The challenges of introducing routine G6PD testing into radical cure: a workshop report.

@en

P2093

April G Dion-Berboso

http://www.w3.org/2001/XMLSchema#string

Benedikt Ley

http://www.w3.org/2001/XMLSchema#string

Chong Chee Kheong

http://www.w3.org/2001/XMLSchema#string

Eugenie Poirot

http://www.w3.org/2001/XMLSchema#string

Fe Esperanza Espino

http://www.w3.org/2001/XMLSchema#string

Gonzalo J Domingo

http://www.w3.org/2001/XMLSchema#string

Jimee Hwang

http://www.w3.org/2001/XMLSchema#string

Lek Dysoley

http://www.w3.org/2001/XMLSchema#string

Michael Kalnoky

http://www.w3.org/2001/XMLSchema#string

Nick Luter

http://www.w3.org/2001/XMLSchema#string

P2860

Structural studies of glucose-6-phosphate and NADP+ binding to human glucose-6-phosphate dehydrogenase

G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications

Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report

Glucose-6-phosphate dehydrogenase deficiency

The impact of phenotypic and genotypic G6PD deficiency on risk of plasmodium vivax infection: a case-control study amongst Afghan refugees in Pakistan

G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map

Vivax malaria: neglected and not benign

Impact of the method of G6PD deficiency assessment on genetic association studies of malaria susceptibility.

Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects

Present status and future concerns of expanded newborn screening in malaysia: sustainability, challenges and perspectives

P2888

s12936-015-0896-8

P304

377

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12936-015-0896-8

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Kamala Thriemer

Lorenz von Seidlein

Germana Bancone

P577

2015-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282513819

http://www.w3.org/2001/XMLSchema#string

P6179

1029418936

http://www.w3.org/2001/XMLSchema#string

P698

26416229

http://www.w3.org/2001/XMLSchema#string

P921

P932

4587750

http://www.w3.org/2001/XMLSchema#string